We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Simple Saliva Test May Help Diagnose Kidney Disease

By Michal Siman-Tov
Posted on 29 Nov 2016
Print article
A preliminary study suggests that a dipstick test for salivary urea nitrogen could be accurate for diagnosing kidney disease and may help predict patients' risk of early death. The test would be especially helpful in developing countries where simple and inexpensive tools for diagnosing kidney disease are most needed.

The study was highlighted at the American Society of Nephrology’s (Washington, DC, USA) Kidney Week 2016 (November 15-20, Chicago, IL, USA), and summarized in Abstract 5710 under the title "Saliva Urea Nitrogen Dipstick: a simple tool to detect and stratify risk of renal disease in low resource settings."

Viviane Calice-Silva, MD, PhD, of the Pro-Kidney Foundation in Brazil, and colleagues evaluated the diagnostic performance of a salivary urea nitrogen (SUN) dipstick in Malawi, Africa, a low-resource country. Among 742 adult individuals who were studied, investigators diagnosed 146 patients with kidney disease using standard tests. High SUN levels were associated not only with the standard diagnostic tests, but also with a higher risk of early death.

"Our data suggest that SUN can improve the detection of kidney disease, increasing the awareness to this devastating complication," said Dr. Calice-Silva, "Also, higher awareness and detection of kidney disease in low-resource settings may increase the number of patients who are diagnosed and referred, therefore providing appropriate treatment and improving outcomes."

Related Links:
American Society of Nephrology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.